Adaptive Immune Responses following Senecavirus A Infection in Pigs

Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present stu...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 92; no. 3
Main Authors Maggioli, Mayara F, Lawson, Steve, de Lima, Marcelo, Joshi, Lok R, Faccin, Tatiane C, Bauermann, Fernando V, Diel, Diego G
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present study, humoral and cellular immune responses to SVA were evaluated following infection in pigs. We show that SVA infection elicited an early and robust virus-neutralizing (VN) antibody response, which coincided and was strongly correlated with VP2- and VP3-specific IgM responses. Notably, the neutralizing antibody (NA) responses paralleled the reduction of viremia and resolution of the disease. Analysis of the major porcine T-cell subsets revealed that during the acute/clinical phase of SVA infection (14 days postinfection [p.i.]), T-cell responses were characterized by an increased frequency of αβ T cells, especially CD4 T cells, which were first detected by day 7 p.i. and increased in frequency until day 14 p.i. Additionally, the frequency of CD8 and double-positive CD4 CD8 T cells (effector/memory T cells) expressing interferon gamma (IFN-γ) or proliferating in response to SVA antigen stimulation increased after day 10 p.i. Results presented here show that SVA elicits B- and T-cell activation early upon infection, with IgM antibody levels being correlated with early neutralizing activity against the virus and peak B- and T-cell responses paralleling clinical resolution of the disease. The work provides important insights into the immunological events that follow SVA infection in the natural host. Senecavirus A (SVA) has recently emerged in swine, causing outbreaks of vesicular disease (VD) in major swine-producing countries around the world, including the United States, Brazil, China, Thailand, and Colombia. Notably, SVA-induced disease is clinically indistinguishable from other high-consequence VDs of swine, such as FMD, swine vesicular disease, vesicular stomatitis, and vesicular exanthema of swine. Despite the clinical relevance of SVA-induced VD, many aspects of the virus infection biology remain unknown. Here, we assessed host immune responses to SVA infection. The results show that SVA infection elicits early B- and T-cell responses, with the levels of VN antibody and CD4 T-cell responses paralleling the reduction of viremia and resolution of the disease. SVA-specific CD8 T cells are detected later during infection. A better understanding of SVA interactions with the host immune system may allow the design and implementation of improved control strategies for this important pathogen of swine.
AbstractList Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present study, humoral and cellular immune responses to SVA were evaluated following infection in pigs. We show that SVA infection elicited an early and robust virus-neutralizing (VN) antibody response, which coincided and was strongly correlated with VP2- and VP3-specific IgM responses. Notably, the neutralizing antibody (NA) responses paralleled the reduction of viremia and resolution of the disease. Analysis of the major porcine T-cell subsets revealed that during the acute/clinical phase of SVA infection (14 days postinfection [p.i.]), T-cell responses were characterized by an increased frequency of αβ T cells, especially CD4 + T cells, which were first detected by day 7 p.i. and increased in frequency until day 14 p.i. Additionally, the frequency of CD8 + and double-positive CD4 + CD8 + T cells (effector/memory T cells) expressing interferon gamma (IFN-γ) or proliferating in response to SVA antigen stimulation increased after day 10 p.i. Results presented here show that SVA elicits B- and T-cell activation early upon infection, with IgM antibody levels being correlated with early neutralizing activity against the virus and peak B- and T-cell responses paralleling clinical resolution of the disease. The work provides important insights into the immunological events that follow SVA infection in the natural host. IMPORTANCE Senecavirus A (SVA) has recently emerged in swine, causing outbreaks of vesicular disease (VD) in major swine-producing countries around the world, including the United States, Brazil, China, Thailand, and Colombia. Notably, SVA-induced disease is clinically indistinguishable from other high-consequence VDs of swine, such as FMD, swine vesicular disease, vesicular stomatitis, and vesicular exanthema of swine. Despite the clinical relevance of SVA-induced VD, many aspects of the virus infection biology remain unknown. Here, we assessed host immune responses to SVA infection. The results show that SVA infection elicits early B- and T-cell responses, with the levels of VN antibody and CD4 + T-cell responses paralleling the reduction of viremia and resolution of the disease. SVA-specific CD8 + T cells are detected later during infection. A better understanding of SVA interactions with the host immune system may allow the design and implementation of improved control strategies for this important pathogen of swine.
Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present study, humoral and cellular immune responses to SVA were evaluated following infection in pigs. We show that SVA infection elicited an early and robust virus-neutralizing (VN) antibody response, which coincided and was strongly correlated with VP2- and VP3-specific IgM responses. Notably, the neutralizing antibody (NA) responses paralleled the reduction of viremia and resolution of the disease. Analysis of the major porcine T-cell subsets revealed that during the acute/clinical phase of SVA infection (14 days postinfection [p.i.]), T-cell responses were characterized by an increased frequency of αβ T cells, especially CD4 T cells, which were first detected by day 7 p.i. and increased in frequency until day 14 p.i. Additionally, the frequency of CD8 and double-positive CD4 CD8 T cells (effector/memory T cells) expressing interferon gamma (IFN-γ) or proliferating in response to SVA antigen stimulation increased after day 10 p.i. Results presented here show that SVA elicits B- and T-cell activation early upon infection, with IgM antibody levels being correlated with early neutralizing activity against the virus and peak B- and T-cell responses paralleling clinical resolution of the disease. The work provides important insights into the immunological events that follow SVA infection in the natural host. Senecavirus A (SVA) has recently emerged in swine, causing outbreaks of vesicular disease (VD) in major swine-producing countries around the world, including the United States, Brazil, China, Thailand, and Colombia. Notably, SVA-induced disease is clinically indistinguishable from other high-consequence VDs of swine, such as FMD, swine vesicular disease, vesicular stomatitis, and vesicular exanthema of swine. Despite the clinical relevance of SVA-induced VD, many aspects of the virus infection biology remain unknown. Here, we assessed host immune responses to SVA infection. The results show that SVA infection elicits early B- and T-cell responses, with the levels of VN antibody and CD4 T-cell responses paralleling the reduction of viremia and resolution of the disease. SVA-specific CD8 T cells are detected later during infection. A better understanding of SVA interactions with the host immune system may allow the design and implementation of improved control strategies for this important pathogen of swine.
Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present study, humoral and cellular immune responses to SVA were evaluated following infection in pigs. We show that SVA infection elicited an early and robust virus-neutralizing (VN) antibody response, which coincided and was strongly correlated with VP2- and VP3-specific IgM responses. Notably, the neutralizing antibody (NA) responses paralleled the reduction of viremia and resolution of the disease. Analysis of the major porcine T-cell subsets revealed that during the acute/clinical phase of SVA infection (14 days postinfection [p.i.]), T-cell responses were characterized by an increased frequency of αβ T cells, especially CD4+ T cells, which were first detected by day 7 p.i. and increased in frequency until day 14 p.i. Additionally, the frequency of CD8+ and double-positive CD4+ CD8+ T cells (effector/memory T cells) expressing interferon gamma (IFN-γ) or proliferating in response to SVA antigen stimulation increased after day 10 p.i. Results presented here show that SVA elicits B- and T-cell activation early upon infection, with IgM antibody levels being correlated with early neutralizing activity against the virus and peak B- and T-cell responses paralleling clinical resolution of the disease. The work provides important insights into the immunological events that follow SVA infection in the natural host.IMPORTANCE Senecavirus A (SVA) has recently emerged in swine, causing outbreaks of vesicular disease (VD) in major swine-producing countries around the world, including the United States, Brazil, China, Thailand, and Colombia. Notably, SVA-induced disease is clinically indistinguishable from other high-consequence VDs of swine, such as FMD, swine vesicular disease, vesicular stomatitis, and vesicular exanthema of swine. Despite the clinical relevance of SVA-induced VD, many aspects of the virus infection biology remain unknown. Here, we assessed host immune responses to SVA infection. The results show that SVA infection elicits early B- and T-cell responses, with the levels of VN antibody and CD4+ T-cell responses paralleling the reduction of viremia and resolution of the disease. SVA-specific CD8+ T cells are detected later during infection. A better understanding of SVA interactions with the host immune system may allow the design and implementation of improved control strategies for this important pathogen of swine.
ABSTRACT Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in pigs. Many aspects of SVA interactions with the host and the host immune responses to infection, however, remain unknown. In the present study, humoral and cellular immune responses to SVA were evaluated following infection in pigs. We show that SVA infection elicited an early and robust virus-neutralizing (VN) antibody response, which coincided and was strongly correlated with VP2- and VP3-specific IgM responses. Notably, the neutralizing antibody (NA) responses paralleled the reduction of viremia and resolution of the disease. Analysis of the major porcine T-cell subsets revealed that during the acute/clinical phase of SVA infection (14 days postinfection [p.i.]), T-cell responses were characterized by an increased frequency of αβ T cells, especially CD4 + T cells, which were first detected by day 7 p.i. and increased in frequency until day 14 p.i. Additionally, the frequency of CD8 + and double-positive CD4 + CD8 + T cells (effector/memory T cells) expressing interferon gamma (IFN-γ) or proliferating in response to SVA antigen stimulation increased after day 10 p.i. Results presented here show that SVA elicits B- and T-cell activation early upon infection, with IgM antibody levels being correlated with early neutralizing activity against the virus and peak B- and T-cell responses paralleling clinical resolution of the disease. The work provides important insights into the immunological events that follow SVA infection in the natural host. IMPORTANCE Senecavirus A (SVA) has recently emerged in swine, causing outbreaks of vesicular disease (VD) in major swine-producing countries around the world, including the United States, Brazil, China, Thailand, and Colombia. Notably, SVA-induced disease is clinically indistinguishable from other high-consequence VDs of swine, such as FMD, swine vesicular disease, vesicular stomatitis, and vesicular exanthema of swine. Despite the clinical relevance of SVA-induced VD, many aspects of the virus infection biology remain unknown. Here, we assessed host immune responses to SVA infection. The results show that SVA infection elicits early B- and T-cell responses, with the levels of VN antibody and CD4 + T-cell responses paralleling the reduction of viremia and resolution of the disease. SVA-specific CD8 + T cells are detected later during infection. A better understanding of SVA interactions with the host immune system may allow the design and implementation of improved control strategies for this important pathogen of swine.
Author de Lima, Marcelo
Bauermann, Fernando V
Diel, Diego G
Faccin, Tatiane C
Lawson, Steve
Maggioli, Mayara F
Joshi, Lok R
Author_xml – sequence: 1
  givenname: Mayara F
  surname: Maggioli
  fullname: Maggioli, Mayara F
  organization: Center for Biologics Research and Commercialization (CBRC), South Dakota State University, Brookings, South Dakota, USA
– sequence: 2
  givenname: Steve
  surname: Lawson
  fullname: Lawson, Steve
  organization: Center for Biologics Research and Commercialization (CBRC), South Dakota State University, Brookings, South Dakota, USA
– sequence: 3
  givenname: Marcelo
  surname: de Lima
  fullname: de Lima, Marcelo
  organization: Laboratório de Virologia e Imunologia Animal, Faculdade de Veterinária, Universidade Federal de Pelotas, Pelotas, RS, Brazil
– sequence: 4
  givenname: Lok R
  surname: Joshi
  fullname: Joshi, Lok R
  organization: Center for Biologics Research and Commercialization (CBRC), South Dakota State University, Brookings, South Dakota, USA
– sequence: 5
  givenname: Tatiane C
  surname: Faccin
  fullname: Faccin, Tatiane C
  organization: Programa de Pós-Graduação em Medicina Veterinária, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil
– sequence: 6
  givenname: Fernando V
  surname: Bauermann
  fullname: Bauermann, Fernando V
  organization: Center for Biologics Research and Commercialization (CBRC), South Dakota State University, Brookings, South Dakota, USA
– sequence: 7
  givenname: Diego G
  orcidid: 0000-0003-3237-8940
  surname: Diel
  fullname: Diel, Diego G
  email: diego.diel@sdstate.edu
  organization: Center for Biologics Research and Commercialization (CBRC), South Dakota State University, Brookings, South Dakota, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29142122$$D View this record in MEDLINE/PubMed
BookMark eNpVkEtP3DAQgC20iH2UG2eUYw8NePyI7Uul1arQrZBA0FbcLCeZbF0l9hIni_j3bMtD7WkO8-mb0TcnkxADEnIC9AyA6fNvP9dnFBSoHNQBmQE1OpcSxITMKGUsl1zfT8k8pd-UghCFOCJTZkAwYGxGVsvabQe_w2zddWPA7BbTNoaEKWti28ZHHzbZHQas3M73Y8qW2To0WA0-hsyH7MZv0gdy2Lg24fHrXJAfF1--r77mV9eX69XyKq8EU0NecAO0BjTSAMdSCo66MK6umBZUCFO6whiNSiqtOAfBnW7KgtZMibIUsuQL8vnFux3LDusKw9C71m5737n-yUbn7f-b4H_ZTdxZqZTQRu4FH18FfXwYMQ2286nCtnUB45gsmEIyIanSe_TTC1r1MaUem_czQO2f7nbf3f7tbkHt8dN_X3uH30LzZzerf0I
CitedBy_id crossref_primary_10_3389_fmicb_2024_1387309
crossref_primary_10_1016_j_virol_2023_06_004
crossref_primary_10_1016_j_micpath_2021_105022
crossref_primary_10_1186_s12985_021_01679_w
crossref_primary_10_3390_v13112300
crossref_primary_10_1016_j_vaccine_2022_02_018
crossref_primary_10_1128_spectrum_04472_22
crossref_primary_10_1186_s40813_023_00353_7
crossref_primary_10_1128_spectrum_02090_22
crossref_primary_10_3389_fvets_2022_923878
crossref_primary_10_1128_spectrum_05229_22
crossref_primary_10_1016_j_vetmic_2023_109958
crossref_primary_10_1128_spectrum_01029_23
crossref_primary_10_3390_vaccines8030532
crossref_primary_10_1016_j_mcp_2020_101643
crossref_primary_10_3389_fmicb_2023_1235620
crossref_primary_10_3390_vaccines10020170
crossref_primary_10_1016_j_vetmic_2019_02_019
crossref_primary_10_3389_fvets_2022_1011975
crossref_primary_10_54846_jshap_1270
crossref_primary_10_3390_v14010127
crossref_primary_10_1007_s12250_018_0056_8
crossref_primary_10_1016_j_vetmic_2024_110011
crossref_primary_10_1016_j_virol_2022_12_001
crossref_primary_10_1186_s12985_022_01791_5
crossref_primary_10_3389_fmicb_2018_00940
crossref_primary_10_1099_jgv_0_001643
crossref_primary_10_3389_fimmu_2019_02660
crossref_primary_10_1016_j_vetmic_2020_108946
crossref_primary_10_1186_s12985_022_01934_8
crossref_primary_10_3389_fimmu_2019_00363
crossref_primary_10_1099_jgv_0_001788
crossref_primary_10_1128_JVI_00819_19
crossref_primary_10_1111_tbed_14310
crossref_primary_10_1016_j_prevetmed_2019_01_012
crossref_primary_10_3390_vaccines10040631
crossref_primary_10_1016_j_virusres_2020_198177
crossref_primary_10_1007_s00705_023_05951_y
crossref_primary_10_1016_j_micpath_2019_103695
crossref_primary_10_1080_21505594_2024_2333562
crossref_primary_10_3390_pathogens9010039
crossref_primary_10_1016_j_virol_2023_06_006
crossref_primary_10_1016_j_virusres_2020_198038
Cites_doi 10.1016/S0378-1135(99)00145-5
10.1111/tbed.12669
10.1007/BF00918150
10.4049/jimmunol.1301439
10.1038/nrmicro1284
10.1128/JVI.00388-16
10.1099/jgv.0.000631
10.1016/j.dci.2004.08.006
10.1016/j.virusres.2006.12.005
10.1155/2013/475960
10.1128/jvi.65.7.3475-3480.1991
10.1371/journal.pone.0070552
10.1016/S0168-1702(98)00035-5
10.1099/0022-1317-79-9-2249
10.1099/vir.0.068270-0
10.1111/tbed.12516
10.1007/s12250-012-3255-8
10.1111/tbed.12410
10.1128/JVI.00447-11
10.1128/JCM.03390-15
10.1186/s12917-016-0716-6
10.1128/JVI.72.6.4866-4873.1998
10.1128/JVI.01701-16
10.1002/eji.1830191107
10.1183/09031936.00149109
10.1016/S1074-7613(00)80147-8
10.1128/JVI.02613-08
10.1007/s00705-007-0941-1
10.1128/genomeA.01509-15
10.1371/journal.pone.0146211
10.1111/tbed.12654
10.1099/0022-1317-70-2-395
10.1111/tbed.12430
10.5501/wjv.v1.i3.91
10.3201/eid2207.151863
10.1371/journal.pone.0162750
10.1177/1040638711426323
10.1099/vir.0.069062-0
10.1089/vim.2007.0097
10.1073/pnas.85.21.8281
10.1016/j.molimm.2014.10.025
10.1016/j.virol.2016.07.003
10.1128/JVI.80.5.2369-2379.2006
10.1128/JVI.75.23.11621-11629.2001
ContentType Journal Article
Copyright Copyright © 2018 American Society for Microbiology.
Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology
Copyright_xml – notice: Copyright © 2018 American Society for Microbiology.
– notice: Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1128/JVI.01717-17
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Adaptive Immune Responses to Senecavirus A
EISSN 1098-5514
Editor Silvestri, Guido
Editor_xml – sequence: 1
  givenname: Guido
  surname: Silvestri
  fullname: Silvestri, Guido
ExternalDocumentID 10_1128_JVI_01717_17
29142122
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
  grantid: SD00H517-14
– fundername: ;
  grantid: SD-CBRC
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
HYE
HZ~
IH2
KQ8
N9A
NPM
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
UPT
W2D
W8F
WH7
WOQ
YQT
ZA5
~02
~KM
.55
.GJ
3O-
41~
6TJ
AAYJJ
AAYXX
AFFNX
AGVNZ
AI.
C1A
CITATION
D0S
F20
H13
MVM
OHT
VH1
X7M
Y6R
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c427t-63910d1e95913eb543e869adc2840449ba6998e7578733143a8fb60d274bb45b3
IEDL.DBID RPM
ISSN 0022-538X
IngestDate Tue Sep 17 20:34:29 EDT 2024
Sat Aug 17 00:59:15 EDT 2024
Thu Sep 12 17:16:51 EDT 2024
Thu May 23 23:53:51 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords vesicular disease
SVV
virus-host interactions
Seneca Valley virus
SVA
Language English
License Copyright © 2018 American Society for Microbiology.
All Rights Reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c427t-63910d1e95913eb543e869adc2840449ba6998e7578733143a8fb60d274bb45b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Maggioli MF, Lawson S, de Lima M, Joshi LR, Faccin TC, Bauermann FV, Diel DG. 2018. Adaptive immune responses following senecavirus A infection in pigs. J Virol 92:e01717-17. https://doi.org/10.1128/JVI.01717-17.
ORCID 0000-0003-3237-8940
OpenAccessLink https://jvi.asm.org/content/jvi/92/3/e01717-17.full.pdf
PMID 29142122
PQID 1965245078
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5774895
proquest_miscellaneous_1965245078
crossref_primary_10_1128_JVI_01717_17
pubmed_primary_29142122
PublicationCentury 2000
PublicationDate 2018-02-01
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2018
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
Singh K (e_1_3_2_6_2) 2012; 3
References_xml – ident: e_1_3_2_46_2
  doi: 10.1016/S0378-1135(99)00145-5
– volume: 3
  start-page: 123
  year: 2012
  ident: e_1_3_2_6_2
  article-title: Seneca Valley virus and vesicular lesions in a pig with idiopathic vesicular disease
  publication-title: J Vet Sci Technol
  contributor:
    fullname: Singh K
– ident: e_1_3_2_14_2
  doi: 10.1111/tbed.12669
– ident: e_1_3_2_32_2
  doi: 10.1007/BF00918150
– ident: e_1_3_2_42_2
  doi: 10.4049/jimmunol.1301439
– ident: e_1_3_2_15_2
  doi: 10.1038/nrmicro1284
– ident: e_1_3_2_45_2
  doi: 10.1128/JVI.00388-16
– ident: e_1_3_2_4_2
  doi: 10.1099/jgv.0.000631
– ident: e_1_3_2_40_2
  doi: 10.1016/j.dci.2004.08.006
– ident: e_1_3_2_33_2
  doi: 10.1016/j.virusres.2006.12.005
– ident: e_1_3_2_37_2
  doi: 10.1155/2013/475960
– ident: e_1_3_2_18_2
  doi: 10.1128/jvi.65.7.3475-3480.1991
– ident: e_1_3_2_36_2
  doi: 10.1371/journal.pone.0070552
– ident: e_1_3_2_28_2
  doi: 10.1016/S0168-1702(98)00035-5
– ident: e_1_3_2_19_2
  doi: 10.1099/0022-1317-79-9-2249
– ident: e_1_3_2_27_2
  doi: 10.1099/vir.0.068270-0
– ident: e_1_3_2_8_2
  doi: 10.1111/tbed.12516
– ident: e_1_3_2_20_2
  doi: 10.1007/s12250-012-3255-8
– ident: e_1_3_2_11_2
  doi: 10.1111/tbed.12410
– ident: e_1_3_2_21_2
  doi: 10.1128/JVI.00447-11
– ident: e_1_3_2_9_2
  doi: 10.1128/JCM.03390-15
– ident: e_1_3_2_48_2
  doi: 10.1186/s12917-016-0716-6
– ident: e_1_3_2_39_2
  doi: 10.1128/JVI.72.6.4866-4873.1998
– ident: e_1_3_2_5_2
– ident: e_1_3_2_25_2
  doi: 10.1128/JVI.01701-16
– ident: e_1_3_2_38_2
  doi: 10.1002/eji.1830191107
– ident: e_1_3_2_35_2
  doi: 10.1183/09031936.00149109
– ident: e_1_3_2_22_2
  doi: 10.1016/S1074-7613(00)80147-8
– ident: e_1_3_2_30_2
  doi: 10.1128/JVI.02613-08
– ident: e_1_3_2_34_2
  doi: 10.1007/s00705-007-0941-1
– ident: e_1_3_2_12_2
  doi: 10.1128/genomeA.01509-15
– ident: e_1_3_2_7_2
  doi: 10.1371/journal.pone.0146211
– ident: e_1_3_2_13_2
  doi: 10.1111/tbed.12654
– ident: e_1_3_2_29_2
  doi: 10.1099/0022-1317-70-2-395
– ident: e_1_3_2_44_2
– ident: e_1_3_2_10_2
  doi: 10.1111/tbed.12430
– ident: e_1_3_2_16_2
  doi: 10.5501/wjv.v1.i3.91
– ident: e_1_3_2_2_2
  doi: 10.3201/eid2207.151863
– ident: e_1_3_2_24_2
  doi: 10.1371/journal.pone.0162750
– ident: e_1_3_2_31_2
  doi: 10.1177/1040638711426323
– ident: e_1_3_2_43_2
  doi: 10.1099/vir.0.069062-0
– ident: e_1_3_2_23_2
  doi: 10.1089/vim.2007.0097
– ident: e_1_3_2_17_2
  doi: 10.1073/pnas.85.21.8281
– ident: e_1_3_2_41_2
  doi: 10.1016/j.molimm.2014.10.025
– ident: e_1_3_2_3_2
  doi: 10.1016/j.virol.2016.07.003
– ident: e_1_3_2_26_2
  doi: 10.1128/JVI.80.5.2369-2379.2006
– ident: e_1_3_2_47_2
  doi: 10.1128/JVI.75.23.11621-11629.2001
SSID ssj0014464
Score 2.4940543
Snippet Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease (FMD) in...
ABSTRACT Senecavirus A (SVA), an emerging picornavirus of swine, causes vesicular disease (VD) that is clinically indistinguishable from foot-and-mouth disease...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
SubjectTerms Adaptive Immunity
Animals
Antibodies, Neutralizing - immunology
Antibodies, Viral - immunology
Foot-and-Mouth Disease - pathology
Host-Pathogen Interactions
Immunity, Cellular
Immunity, Humoral
Pathogenesis and Immunity
Picornaviridae
Swine
Swine Vesicular Disease - pathology
T-Lymphocytes - immunology
Viremia - immunology
Viremia - veterinary
Title Adaptive Immune Responses following Senecavirus A Infection in Pigs
URI https://www.ncbi.nlm.nih.gov/pubmed/29142122
https://search.proquest.com/docview/1965245078
https://pubmed.ncbi.nlm.nih.gov/PMC5774895
Volume 92
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB7aguBFfBsfZQU9pnltXsdSLE2lUtRKbyG72WjApqVpFf-9s3kUqzfPSZYwO7vzfey33wDcCO4Jh9pCZQlyEyQQphrFhsB1FRmOK5xYFO3eRg_OYEKHU3vaALu-C1OI9jlLO9n7rJOlb4W2cjHjWq0T08ajnu1KzxRba0LTtayaoldHB8hvaG0Rjqt5WqvdTU8bvgQd6Q8jbRGlC7BvyPNQc7sk_cGZv-WSP-pPfx_2KuBIuuUPHkBDZIewU7aS_DqCXjeOFnLrIoG88SHIYyl-FTlJcKrnn1iiyBNubDz6SJfrnHRJUOmwMpJmZJy-5scw6d899wZq1SBB5dR0VyqiC0PHyPq2b1iC2dQSnuNHMceao1Pqs8hBNiWkZb1szUityEuYo8fIRBmjNrNOoJXNM3EGxEg49x3uezpFgsF0hsMljPmSk3GELQrc1jEKF6UPRljwB9MLMaxhEdbQcBW4rgMYYqLK04coE_N1HkrrQpMi_PQUOC0DuhmpngkF3K1Qb16QJtjbTzA3CjPsKhfO__3lBewiCPJKJfYltFbLtbhCoLFibYTYwX27SK9viuHSYQ
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0VEIIL-1JWI8Exa53tWFWgFihCQKveothxIIKmFW1B8PWMkxjRcoKzE8vJsz3z5Oc3AKeC-8KljtBYgtwECYStRbElcF1FlusJNxZ5ubf2jdvs0Mue06uAo-7C5KJ9zlI9e-nrWfqUayuHfW4onZhx2244nvRMcYw5WMD1anuKpJeHB8hwqDIJx_ae0rvbvnHZbenSIUYaI0of4MCSJ6L2dFD6lWnOCiZ_RKCLVeiqsRfCk2d9MmY6_5yxdfzzx63BSpmTknrRvA4VkW3AYlGl8mMTGvU4GspdkbTkZRJB7gpdrRiRBGfR4B2jH7nHPZNHb-nrZETqpFVKvDKSZuQ2fRxtQefi_KHR1MraCxqntjfWMHGxTAQtcAKrJphDa8J3gyjmGM5MSgMWuUjUhHTDl1UfaS3yE-aaMZJcxqjDatswnw0ysQvESjgPXB74JkXuwkyG3SWMBZLuccyIqnCmfn44LCw2wpya2H6IeIU5XqHlVeFEIRPiGpAHG1EmBpNRKF0RbYqZrV-FnQKp754UxFXwpjD8fkD6a0-3IDK5z3aJxN6_3zyGpeZD-zq8bt1c7cMy5lp-Ifg-gPnx60QcYj4zZkf57P0CaZ_zbQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xCMSFfSmrkeCYtc7iY1WoKEtVAUUVlyh2HIiAtKItCL6ecRZEy61nO1ai5_HMk1_eAJxI4UuXOlLjMXITJBC2FkaWxLgKLdeTbiSzdm83LfeiQy-7TvdPq69MtC94oqevb3qaPGfayv6bMEqdmNG-qTue8kxxjH4UG7MwjzFrs5KoFxcIyHJoaRSO491S8277xuVDU1cuMcocUXkBM0vditrjielftTkpmvyThRor8Fi-fy4-edFHQ66L7wlrx6k-cBWWi9qU1PIpazAj03VYyLtVfm1AvRaFfXU6kqb6qUSS21xfKwckxt3U-8QsSO7w7BThR_I-GpAaaRZSr5QkKWknT4NN6DTO7-sXWtGDQRPU9oYaFjCWieAxh1lVyR1alb7LwkhgWjMpZTx0kbBJ5Yqvuj_SaujH3DUjJLucU4dXt2Au7aVyB4gVC8FcwXyTIofhJsflYs6Zon0CK6MKnJYABP3caiPIKIrtB4hZkGEWWF4Fjkt0AowFdcERprI3GgTKHdGmWOH6FdjO0fpdqYS5At4Yjr8TlM_2-Aiik_ltF2jsTv3kESy2zxrBdbN1tQdLWHL5ue57H-aG7yN5gGXNkB9mG_gHJtP17Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adaptive+Immune+Responses+following+Senecavirus+A+Infection+in+Pigs&rft.jtitle=Journal+of+virology&rft.au=Maggioli%2C+Mayara+F.&rft.au=Lawson%2C+Steve&rft.au=de+Lima%2C+Marcelo&rft.au=Joshi%2C+Lok+R.&rft.date=2018-02-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=92&rft.issue=3&rft_id=info:doi/10.1128%2FJVI.01717-17&rft_id=info%3Apmid%2F29142122&rft.externalDBID=PMC5774895
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon